EGC enhances tumor antigen presentation and CD8+ T cell-mediated antitumor immunity via targeting oncoprotein SND1.
Zhang X, Cui X, Li P, Zhao Y, Ren Y, Zhang H, Zhang S, Li C, Wang X, Shi L, Sun T, Hao J, Yao Z, Chen J, Gao X, Yang J.
Zhang X, et al. Among authors: cui x.
Cancer Lett. 2024 May 4:216934. doi: 10.1016/j.canlet.2024.216934. Online ahead of print.
Cancer Lett. 2024.
PMID: 38710299